The mechanisms of neuronal degeneration induced by the transformation of normal cellular prion protein (PrP C ) into disease-associated PrP Sc are not fully understood. Previous reports have demonstrated that cross-linking cellular prion protein by anti-PrP C antibodies can promote neuronal apoptosis. In this report, we now show that treatment of neuronal cells with anti-prion antibodies leads to sequestration of free cholesterol in cell membranes, significant overexpression of apolipoprotein E, and to cytoplasmic phospholipase A2 activation as well as to production of prostaglandin. These results confirm the in vivo toxic effects and indicate that anti-prion antibody treatment of neurons lead to deleterious effects. Finally, great caution should be exerted when adopting antibody-based therapy for prion diseases.
INTRODUCTION
Transmissible spongiform encephalopathies or prion diseases are invariably fatal neurodegenerative diseases (Prusiner, 1994) thought to occur through the post-translational conversion of a normal cell membrane sialoglycoprotein PrP C , composed of primarily a-helical structure, into a disease-specific isoform, PrP Sc that is rich in b-sheet and partially proteinase-resistant (Prusiner, 1998) .
Molecular mechanisms underlying prion infection and the resulting replication/accumulation and neuronal death remain unknown (Chiesa & Harris, 2001 ). However, cellular prion protein, PrP C , plays an important role in these processes as PrP Sc itself is not capable of initiating the neurotoxic effects associated with prion diseases in the absence of PrP C expression, indicating that PrP C is necessary for neurodegeneration to occur (Brandner et al., 1996; Mallucci et al., 2003) . Furthermore, cross-linking PrP C with specific anti-prion antibodies led to neuronal apoptosis in vivo (Jones et al., 2010; Solforosi et al., 2004) and to PrP C -dependent Fyn activation (Mouillet-Richard et al., 2000) and also led to modulation of calciumdependent protein kinase C in mice (Mazzoni et al., 2005) , suggesting a role in signal transduction.
Apolipoprotein E (ApoE) has been associated with the pathogenesis of Alzheimer's disease and has also been recognized in kuru plaques (Van Everbroeck et al., 2001) . ApoE is a glycoprotein that plays an important role in cellular lipid transport and lipoprotein metabolism. High levels of ApoE are expressed in astrocytes, macrophages and hepatocytes, but are also seen in most peripheral tissues (Xu et al., 2006) . Furthermore, increased plasma cholesterol levels have been shown to augment the progression of a number of neurodegenerative diseases including Alzheimer's disease (Puglielli et al., 2003) , Parkinson's disease (Michel & Bakovic, 2007) and prion diseases (Mok et al., 2006; Kempster et al., 2007) .
Several studies have established the crucial role of ApoE in the transport of cholesterol (Kesäniemi et al., 1987; Mahley & Huang, 1999) and its genetic association with phospholipase A 2 (PLA 2 ) (Lung et al., 2006) . The amount of free cholesterol within cell membranes is normally tightly controlled via a mixture of biosynthesis, uptake and efflux to and from the extracellular medium and by esterification of free cholesterol in the endoplasmic reticulum (Chang et al., 1997; Simons & Ikonen, 2000) . The regulation is important as changes in the cholesterol content of membranes may have profound cellular effects. For example, the cholesterol content of cells affects membrane fluidity and subsequently the endocytosis and the intracel-lular trafficking of proteins (Maxfield & Tabas, 2005) . Cholesterol and other sterols are readily oxidized into cytotoxic oxysterols (Sathishkumar et al., 2007) and inhibition of intracellular cholesterol transport induced apoptosis of cortical neurons (Koh et al., 2007) . More specifically, in neurons cholesterol is required for the formation and function of synapses (Goritz et al., 2005; Pfrieger, 2003) .
Although free cholesterol is a component of normal cell membranes, the amounts of free cholesterol are increased up to fivefold in specialized micro-domains within the plasma membrane that are commonly called lipid rafts (Pike, 2004) . The amount of cholesterol in cell membranes is critical for both the formation and function of lipid rafts and fluctuations in membrane cholesterol concentrations have profound effects on raft function. Many of the neurotransmitter receptors, including those for acetylcholine, glutamate and gamma-aminobutyric acid are found in rafts and changes in cholesterol levels may affect neurotransmission (Allen et al., 2007) . Lipid rafts also act as membrane platforms that concentrate molecules for cell signalling (Simons & Toomre, 2000) . They contain components of signalling pathways including the Src family tyrosine kinases (Li et al., 1996) , adenylyl cyclase (Cooper & Crossthwaite, 2006) , the trimeric G-proteins (Oh & Schnitzer, 2001 ) and cytoplasmic PLA 2 (cPLA 2 ) (Graziani et al., 2004) . The unregulated activation of PLA 2 is recognized as a key event in neurodegenerative diseases Sun et al., 2004) as it is the first step in the production of eicosanoids, docosanoids and plateletactivating factors that can cause synapse damage, glial cell activation and neuronal death. Changes in the levels of membrane cholesterol may trigger abnormal cell signalling, which leads to neurodegeneration.
PLA 2 is an enzyme that catalyses the hydrolysis of membrane glycerophospholipids to liberate free fatty acid. Oxidized-low-density lipoproteins (LDL) have been shown to stimulate the release of arachidonic acid and the production of prostaglandins with cPLA 2 involvement (Panini et al., 2001; Yokode et al., 1988) . Furthermore, oxidized-LDL-induced formation of cholesteryl oleate has been suppressed by methyl arachidonyl fluorophosphonate, an inhibitor of cPLA 2 (Kitatani et al., 2002) , indicating that cPLA 2 plays an important role in the release of fatty acids utilized for cholesterol esterification in response to oxidized-LDL (Akiba et al., 2003) . In more recent reports, we have shown that prion infection significantly increases levels of free cholesterol and of cPLA 2 in neuroblastoma cell lines (Bate et al., 2008c) . Moreover, abnormal accumulation of cholesterol esters in peripheral cells has been observed in scrapie-infected sheep and treatment with compounds known to interfere with cholesterol homeostasis lead to significant reduction of cholesterol esters in these cells (Pani et al., 2007) , indicating that cholesterol esterification is an important component in the protection against prion-mediated cell death (Bate et al., 2008a) . In this present study, epitope-specific anti-prion antibodies (Beringue et al., 2003) have been utilized on cell culture models (Pleasure et al., 1992) on rat dorsal root ganglia neurons (DRG) and mouse primary cortical neurons (MPCN) in order to assess antibody-mediated effects on cholesterol homeostasis.
These anti-PrP mAbs included ICSM18, an IgG1 mAb that binds PrP C strongly in its native state, weakly to native PrP Sc , and to both isoforms in Western blots. Its epitope lies between codons 146 and 159 (Fig. 1) , a central region encompassing the first a-helix of PrP C , thought to play an important role in the conversion process (Riek et al., 1996) . Also used was ICSM35, an IgG2b mAb that binds both normal and disease-associated prion protein isoforms from all species tested, whether the protein is in native conformation or denatured. Its epitope lies between residues 96 and 109 (Fig. 1 ). An isotype matched control for ICSM35, called BRIC126 was used. BRIC126 is an IgG2b mAb against a heavily N-glycosylated hydrophobic cell membrane glycoprotein found on erythrocytes and platelets.
RESULTS

Antibody-mediated ApoE overexpression
NTera 2 cells were incubated with varying concentrations of ICSM35 (0.1, 0.5, 1, 5, 10 and 25 mg medium ml 21 ; Fig. 2a) . Here, as little as 0.1 mg ICSM35 ml 21 caused upregulation of ApoE expression (Fig. 2a) . ApoE expression was not proportional to ICSM35 concentration but 25 mg ml 21 led to a significant increase of ApoE and to ApoE aggregation (Fig. 2a) .
Further, ICSM35 Fab (1 and 25 mg ml
21
) were used in other experiments and show similar results (Fig. 2a) , an indication that this effect was not complement mediated.
Surprisingly, ICSM18 did not have any detectable effect either on NTera 2 or DRG cells (Fig. 2a and data not shown), suggesting that ligating this more C-terminal region (146-159) did not induce the ApoE effect. Levels of ApoE were quantified by ELISA following ICSM18 or ICSM35 treatment (Fig. 2b) . Incubation of NTera2 cells with ICSM35 for 1 h significantly increased ApoE secretion in the cell (n54, P,0.01; Fig. 2b ). No change in ApoE secretion was observed when cells were treated with ICSM18 (Fig. 2b) .
ICSM35 was then used to treat NTera 2 cells for defined periods. After exposure of NTera 2 cells to ICSM35 for 1 h, ApoE expression increased dramatically in the cytosol (Fig. 3) . With 1 h treatment with ICSM35, ApoE expression appears to be more diffuse and scattered in the cytosol as opposed to longer treatment (i.e. 48 h and 6 days; Figs 3 and 4), where ApoE aggregation close to the nucleus is observed, indicating that ApoE degradation/clearance following the treatment/stimulation with ICSM35. Primary neuronal cells (DRG) were also treated as above.
Similarly, an increase in ApoE expression was also observed and showed the same pattern of distribution as seen with NTera 2 cells (data not shown). ApoE did not overlap with cytosolic PrP C following ICSM35 treatment (data not shown).
Antibody-mediated disturbances of cholesterol homeostasis in MPCN
Amounts of protein and cholesterol in antibody-treated MPCN were measured and compared with those in untreated neurons. anti-Thy-1 antibody at equivalent concentrations to ICSM35 failed to cause a disturbance in cholesterol homeostasis, indicating a PrP-specific effect (data not shown). In conclusion, ICSM35 but not ICSM18 treatment of MPCN was associated with a significant decrease in the amounts of cholesterol esters, but increased free cholesterol.
Antibody-mediated cPLA 2 increase in MPCN
ApoE, cholesterol and PLA 2 polymorphisms have been shown to interact and influence progression of some neurodegenerative diseases (Lung et al., 2006) . Furthermore, PLA 2 plays a pivotal role in some inflammatory processes through the release of free arachidonic acid, a key component in the production of lipid mediators and is metabolized by cyclooxygenases into prostaglandins ). Finally and to confirm cPLA 2 activity in antibody-treated MPCN, prostaglandin E2 (PGE 2 ) produced by antibody-treated MPCN was quantified (Fig. 5b) both ICSM35 and ICSM18, we show a big difference in the amounts of PGE 2 in MPCN with the highest levels following ICSM35 treatment.
In conclusion and similar to both ApoE and cholesterol, activated cPLA 2 (and PGE 2 ) was only upregulated with ICSM35 treatment and not with ICSM18 (Fig. 5) , strongly indicating that PrP C -antibody associated effect and striking pattern abnormalities are linked to an epitope located on the N-terminal region of the prion protein.
Assessment of mitochondrial trans-membrane potential
Free cholesterol elevation above a physiological level leads to plasma membrane loss of fluidity which in turn adversely affects certain integral membrane proteins that require conformational freedom for proper function (Tabas, 2002) . Similar observations have been made with proteins residing in internal membranes, such as the ATP-ADP transporter in the inner mitochondrial membrane, leading to mitochondrial dysfunctions induced by altered cholesterol metabolism (Tabas, 2002) .
The lipophilic cation, 5,59,6,69tetrachloro-1,19,3,39-tetraethylbenzimidazol-carbocyanine iodide (JC-1) (Molecular Probe) was used to detect variations in mitochondrial membrane potential (DY) at the single-cell level. Both NTera 2 cells and DRGs were treated with ICSM18 ( Fig. 6a and b) or ICSM35 ( Fig. 6c and d) . Of note, JC-1 changes reversibly its colour from green to orange as membrane potentials increase (over values of about 80-100 mV). This property is due to the reversible formation of JC-1 aggregates upon membrane polarization that causes shifts in emitted light from 530 nm (i.e. emission of JC-1 monomeric form) to 590 nm (i.e. emission of J-aggregate) when excited at 490 nm. Thus, the colour of the dye changes reversibly from green to greenish orange as the mitochondrial membrane becomes more polarized.
Treatment of both type of cells with ICSM35 (whole or Fab) mainly led to the detection of J-aggregates ( Fig. 6c  and d ), similar to H 2 O 2 addition (data not shown). Concentration of H 2 O 2 used here normally leads to oxidative stress and apoptosis. This is a strong indication of ICSM35-mediated cell membrane alterations.
In contrast, both ICSM18 and BRIC126 (Fig. 6a and b and data not shown) have demonstrated an increase of Jmonomers.
These results seem to follow similar pattern of ApoE, cholesterol homeostasis, cPLA 2 and PGE 2 changes seen with ICSM antibody treatment of MPCN. (Ma et al., 2002) . In contrast, PrP C being a GPI-anchored molecule is readily available for antibody interactions and neutralization.
Cholesterol homeostasis in cells is regulated by a complex set of mechanisms that include cholesterol synthesis, cholesterol esterification and cholesterol efflux. In this study, we show that cross-linking PrP C by using anti-PrP mAbs alters cholesterol homeostasis in vitro. Here, we have demonstrated that the antibody-mediated effect on cholesterol seems to be limited to specific motifs of the prion protein localized to the N-terminal region of the truncated prion protein, although more regions should be assessed. Cholesterol homeostasis disturbances have previously been linked to neurodegenerative disease progression, including prion diseases (Kempster et al., 2007; Mok et al., 2006) .
Interaction between cholesterol and ApoE is associated with neurodegenerative disease progression. Moreover, ApoE plays an important role in neuronal membrane repair mechanisms or further, provides a more direct protective role against oxidative insult (Mahley & Huang, 1999) . ApoE is thought to play an important neuroprotective role against ischaemia (Kitagawa et al., 2002) and is also present in many cerebral and systemic amyloidoses, and prion disorders (Diedrich et al., 1991) . Recombinant PrP has been shown to form stable complexes with ApoE (Gao et al., 2006) and a similar structural motif was recognized in amyloidogenic prion fragments and ApoE (Baumann et al., 2000) . Furthermore, it has been demonstrated that ApoE is involved in fibril formation and amyloid deposition (Castaño & Frangione, 1995) . Interestingly, ApoE localized in the perinuclear region of the cell following ICSM35 treatment for 24 h. In contrast, long-term treatment with ICSM35 led to the formation of large ApoE aggregates that co-localize with Golgi. Previous studies on lipoprotein stimulation of ApoE secretion in a cell model demonstrated that a proportion of the newly synthesized ApoE was degraded intracellularly (Ye et al., 1992) . Furthermore, and in other studies, Ye et al. (1993) demonstrated that ApoE is degraded in a post-Golgi compartment in cells. In contrast, our results seem to suggest a different outcome as NTera 2 cells did show co-localization of ApoE and Golgi after ICSM35 treatment. Increased ApoE may correspond to an attempt by neuronal cells to repair or limit damage caused by anti-prion antibodies and could explain the upregulation, but also the formation of ApoE aggregates after long-term treatment with antibodies. It has previously been shown that recycling of ApoE is linked to intracellular cholesterol transport (Heeren et al., 2003 (Heeren et al., , 2004 . It could therefore be speculated that antibody treatment alters transport of ApoE to the cell surface as a consequence of increased cholesterol accumulation and formed aggregates near Golgi.
It is widely documented that ApoE is present in high concentrations in neurons following brain injury (Horsburgh et al., 1997 (Horsburgh et al., , 1999 Horsburgh & Nicoll, 1996) . Moreover, some studies have also demonstrated that increased ApoE expression leads to synaptic regeneration (White et al., 2001) . In contrast, in ApoE-deficient mice, synaptic plasticity and regeneration are impaired (Krugers et al., 1997) . It could be speculated that increased ApoE levels that follows anti-prion antibody treatment is an attempt to rescue neurons, similar to previous findings where increased levels of ApoE in vivo significantly reduces the extent of neuronal and oxidative damage in ApoEdeficient mice following ischaemia (Horsburgh et al., 2000) .
Significant elevations of total cholesterol were demonstrated in ICSM35-treated MPCN compared with their untreated counterparts, specifically an increase of free cholesterol at the cell membrane level. This increase was comparable to what has been recently described in prioninfected cell lines (Bate et al., 2008b) and in prion-infected mice (Russelakis-Carneiro et al., 2004) .
It is not clear how antibody binding to PrP
C disrupts cholesterol homeostasis leading to increased cholesterol levels. Other reports have shown that addition of a mAb against endosomal membrane lipid resulted in an increase of cholesterol esters and cell surface cholesterol (DeltonVandenbroucke et al., 2007) , suggesting that the effects seen with antibody treatment on cholesterol homeostasis may be due to increased cholesterol production.
A physiological free cholesterol : phospholipid ratio in cellular membranes is crucial in maintaining proper membrane fluidity. Thus, cholesterol depletion leads to marked disruption of specific micro-domains within cell membranes called lipid rafts. Lipid rafts may become too rigid and lose their fluidity when the free cholesterol : phospholipid ratio rises above a physiological level (Tabas, 2002) . This cholesterol depletion adversely affects integral membrane proteins that require conformational freedom for proper function.
Excess membrane cholesterol may disrupt the function of signalling proteins that reside in membrane domains, including cPLA 2 , which has been shown to be reduced in cholesterol-depleted cells (Bate et al., 2008b) . Previous reports linked inhibition of cholesterol synthesis to decreased formation of PrP Sc and delay of scrapie infection. Recently, we tested the effects of polyunsaturated fatty acids, known to inhibit cholesterol formation, on PrP Sc formation and PLA 2 activation in vitro (Bate et al., 2008b) . Treatment with polyunsaturated fatty acids significantly increased PLA 2 activity and PGE 2 production in chronically prion-infected cell lines (Bate et al., 2008b ). In the current study, we show that ICSM35-treatment of MPCN led to a substantial increase of the levels of activated cPLA 2 protein compared with untreated cells. This cPLA 2 activation was also associated with an increase in PGE 2 production; similar to findings described in vitro (Bate et al., 2008b) and scrapieinfected mice (Williams et al., 1994) .
Similarly, proteins residing in internal membranes can also be disrupted by such events. For instance, widespread mitochondrial dysfunction such as cytochrome c release into the cytosol as well as activation of caspase-9 and effector caspases, indicated by a decrease in the mitochondrial transmembrane potential, is also observed in cells with elevated free cholesterol (Tabas, 2002) , just as we found. After treatment with ICSM35, cells showed a significant increase in mitochondrial membrane potential compared with cells treated with ICSM18 and BRIC126. This is an indication of mitochondrial membrane potential alteration caused by mitochondrial membrane disturbance mediated through cross-linking specific motif of PrP C with antibody.
The mode of action of these anti-prion antibodies leading to abnormal changes in cholesterol homeostasis and increased cPLA 2 activity remains unknown, but our experiments suggest it is mediated through specific regions of PrP C , although we have not defined the specific intracellular pathways modulated by this differential signalling. Of note, ICSM antibodies are not able to enter the cell but bind to surface membrane-bound PrP C (Beringue et al., 2004) , indicating that the above events are triggered through cross-linking surface PrP C .
In conclusion, we show that cross-linking PrP C with antiprion antibodies directed to the N-terminal region of the truncated prion protein leads to increased ApoE expression, abnormal cholesterol homeostasis with significant increase of free cholesterol, cell signal alteration through increased cPLA 2 activity and disruption of membrane fluidity, mimicking the in vitro findings of prion-mediated cholesterol disturbances by several groups.
Antibodies that target the N-terminal region of the cellular prion protein seem to lead to a loss of function of the protein and could explain the abnormalities associated with ICSM35 treatment. This specific N-terminal region necessitates further investigation in depicting the molecular mechanism(s) and pathway(s) associated with cell signalling and cell survival. As far as implications for immunotherapy and for that matter, any therapeutic strategy targeting PrP C is concerned, consideration must be given to which region of the prion protein is targeted in order to avoid potential deleterious effects.
METHODS
Cell culture. For this study, we used the NTera 2 cell line (Pleasure et al., 1992) , a human teratocarcinoma cell line that displays a stable and irreversible neuronal phenotype as assessed by the lack of mitotic activity or phenotypic reversion over a period of 2 months in culture. NTera 2 cells express a variety of neuronal markers including many neuronal cytoskeletal proteins, secretory markers and surface markers. They resemble primary neuronal cultures from rodents morphologically and in density of process outgrowth and, like primary neurons, go on to elaborate processes that differentiate into axons and dendrites.
NTera 2 cultures were plated at 2-4610 6 in Opti-MEM medium (Gibco-BRL) [0.5 % (w/v) glucose supplemented with 5 % FBS, 50 U penicillin ml 21 , 50 mg streptomycin ml 21 and 200 mM L-glutamine]. Cultures were maintained at 37 uC in 5 % CO 2 with a change of medium every 48-72 h.
For subsequent treatment with anti-prion antibodies, NTera 2 cells were plated onto Matrigel-coated coverslips using six-or 24-well plates (Falcon) at 0.5-2610 5 cells per well and grown to confluence at 37 uC in 5 % CO 2 for a minimum of 48 h. Groups of cells were then grown to confluence and after a change of medium (Opti-MEM), cells were treated with either 1 or 25 mg ICSM35 ml 21 for 0, 1, 12, 36 or 48 h, or for 6 days. For long-term treatment (i.e. 48 h), antibody-containing medium was changed daily. After removing excess antibody, the cells were fixed before being stained with antiApoE, anti-tubulin and DAPI (nuclear stain). No antibody treatment and isotype-matched controls were used (BRIC126) (Fig. 2a) .
Primary cultures of rat peripheral nerve DRG tissue were used to assess the effects of anti-prion antibodies on ApoE expression. DRGs were isolated as described previously (Roediger & Armati, 2003 ) and were used as described for NTera 2 cells. MPCN were prepared from the brains of embryos as described previously (Bate et al., 2008b) . Briefly, neuronal precursors were plated in Hams F12 containing 5 % FBS for 2 h. Following removal of non-adherent cells, neurons were grown in neurobasal medium (NBM) containing B27 components (Invitrogen) for 7 days and subsequently incubated with antibodies.
Protein extraction from cells. Cells were washed twice in PBS and homogenized in an extraction buffer containing 10 mM Tris/HCl, 100 mM NaCl, 10 mM EDTA, 0.5 % Nonidet P-40, 0.5 % sodium deoxycholate and 0.2 % SDS at 10 6 cells ml
21
. Mixed protease inhibitors (AEBSF, Aprotinin, Leupeptin, Bestain, Pepstatin A and E-46; Sigma) were added to some cell extracts. Membranes were prepared by repeated passage with a Wheaton homogenizer; nuclei and large fragments were removed by centrifugation (300 g for 5 min).
Antibodies. The following antibodies were purchased: mouse anti-human b-tubulin III (Promega), goat anti-human ApoE (Calbiochem), rabbit anti-goat-FITC (Sigma), sheep anti-mouseTexas red and streptavidin-TR (Amersham). Anti-Golgi antibody was purchased from GeneTex, mouse anti-cPLA 2 from Upstate, rabbit polyclonal anti-phospho-cPLA 2 from Cell Signaling Technology, biotinylated anti-rabbit IgG from Dako, anti-Thy-1 from Serotec and BRIC126 was kindly provided by Dr Rosey Mushens (IBGRL, Bristol, UK) (Anstee et al., 1991) . Anti-prion protein antibodies, ICSM18 and ICSM35 (Beringue et al., 2003) were purchased from D-Gen Ltd.
Fluorescence microscopy. Immunofluorescence was performed as described previously (Roediger & Armati, 2003) with slight modifications. Briefly, cell cultures adherent to Matrigel on coverslips were rinsed three times in TBS (1 M Tris/HCl, 1.5 M NaCl, pH 7.5). For binding of cell surface antigens, cells were fixed in 300-500 ml cold (4 uC) 3.5-4 % (w/v) paraformaldehyde (Ajax Chemicals) in TBS for 20 min at room temperature prior to washing and blocking. For detection of cytoplasmic antigens, cells were permeabilized with 300-500 ml 0.2 % (v/v) Triton X-100 (Bio-Rad) in TBS for 5 min at room temperature. After washing the coverslips with TBS, 100 ml blocking buffer [1 % (v/v) FBS, 1 % BSA (w/v) in TBS] was added. The coverslips were then incubated with 100 ml primary antisera diluted in TBS [(mouse anti-b-tubulin III, 1 : 2000; goat anti-human ApoE, 1 : 1000) overnight at 4 uC. After subsequent washes in TBS, coverslips were then incubated in 100 ml secondary antisera diluted in TBS (rabbit anti-goat-FITC, sheep anti-mouse-FITC, streptavidinTexas red) for 1 h at room temperature. After the final wash in TBS, the coverslips were mounted in fluorescence anti-fade solution (Vector Laboratory) and sealed with clear nail polish to prevent dehydration. DAPI (Sigma Chemical) was diluted to 2 mg ml 21 in fluorescence anti-fade solution for nuclear staining.
Fluorescence microscopy was performed with a Nikon E800 microscope. Images from each source [FITC (450-490 nm), Texas red (510-560 nm) and DAPI (330-380 nm)] were collected by a CCD (Sensicam) from the same field-of-view. Images were merged using Photoshop 5.0 (Adobe).
Confocal laser scanning microscopy was performed with a Leica TCS SP2 (Leica Microsystem) confocal system on an inverted microscope DM IRE2. Z-series and snapshot images were collected. Dual scans were merged using Photoshop 5.0 (Adobe).
Quantification by ELISA of cellular ApoE accumulation.
Following protein extraction from cells, 20 mg protein aliquots of cell lysates were used for ApoE quantification by ELISA as described previously (Mabile et al., 2003) .
Fluorometric quantification of cholesterol in MPCN. Cellular cholesterol and protein content were determined in cell extracts derived from 10 6 cells. Cholesterol quantification was performed using the Amplex Red cholesterol assay kit according to the manufacturer's instructions (Invitrogen). Briefly, in this assay cholesterol is oxidized by cholesterol oxidase to yield H 2 O 2 and ketones. H 2 O 2 reacts with Amplex Red reagent (10-acetyl-3, 7-dihydroxyphenoxazine) to produce highly fluorescent resorufin. By performing the assay in the presence or absence of 59 U cholesterol esterase (Sigma) ml 21 , the assay can also determine the amounts of cholesterol esters within samples. Values shown are the mean of six independent experiments.
Quantification of cPLA 2 in MPCN. The amount of activated cPLA 2 in cell extracts was measured by a sandwich ELISA. Activation of cPLA 2 is accompanied by phosphorylation of the 505 serine residue measured by phospho-specific antibodies.
In an assay based on this phenomenon, 0.5 mg mouse mAb anticPLA 2 (Upstate) ml 21 in carbonate-coating buffer was added to medium-binding ELISA plates (Greiner) then incubated for 1 h at 37 uC with shaking. The plates were subsequently blocked with 10 % FBS for 1 h at room temperature. After decanting the blocking buffer, cell extracts were added and incubated for 1 h at 37 uC. Activated cPLA 2 was detected using a rabbit polyclonal anti-phospho-cPLA 2 (Cell Signaling Technology). Finally, the plates were developed with substrate solution until optimum development was seen and the reaction stopped with stop solution prior to spectrophotometric reading at 450 nm. The concentration of activated cPLA 2 was calculated from a standard curve using non-linear regression. Samples were expressed as 'units cPLA 2 ' where 100 U were defined as the amount of cPLA 2 in 10 6 untreated neuronal cells. A standard curve was generated from this sample using sequential log 2 dilutions (range 100-1.56 U per well). Values shown are the mean of eight independent experiments.
Quantitative determination of PGE 2 in neuronal cell extracts.
Prostaglandins are lipid mediators that participate in the regulation of immunological and inflammatory responses and are generated through the activation of the PLA 2 -COX cascade (Lucas et al., 2005) . To determine prostaglandin activity, we used an assay that was based on the competitive binding of PGE 2 present in neuronal cell extracts and a fixed amount of labelled PGE 2 for a PGE 2 -specific mAb. Following colour development and measuring absorbance at 450 nm, the intensity of the colour was found to be inversely proportional to the concentration of PGE 2 in the cell extracts. The detection limit of this assay is 20 pg ml
. Values shown are the mean of six independent experiments.
Mitochondrial trans-membrane potential analysis. A specially designed chamber that permits slow and constant flow of HEPES buffer (Life Technologies) under 2-photon microscope visualization that measures fluorescence after the addition JC-1 prevented the cell drying at room temperature. This was performed using cells passaged onto 22 mm Matrigel-coated coverslips, cultured in Opti-MEM medium and maintained at 37 uC with 5 % CO 2 for 2-4 days, washed in HEPES buffer (140 mM NaCl, 2 mM CaCl 2 , 5 mM KCl, 20 mM HEPES and 10 mM glucose in MilliQ water, at pH 7.4) at 37 uC.
Leica TCS SP2 (Leica Microsystem) confocal system on an inverted microscope equipped with HCXPl Apo CS 663 water immersion objective and UV correction (NA 1.2) was used to visualize transmembrane potential change. Experiments were performed at room temperature in a darkened room. JC-1 was excited in 2-photon mode with the 488 nm laser line and images were collected at red (TRITC, LP590 nm) and green (FITC, BF530/30) channels in parallel.
The emission fluorescence was collected in red (.580 nm) and green (500-660 nm) as well as phase-contrast channels simultaneously. Results shown are representative of three independent experiments.
